In this video, Anita Afzali, MD, MPH, from The Ohio State University Wexner Medical Center, discusses challenges in the transition from pediatric to adult care in inflammatory bowel disease.
According to William Boden, MD, the COURAGE Risk Prediction Tool is one of the most important developments to come from the COURAGE Trial. In this video, Dr Boden explains how the the tool works and what...
Tom Rifai, MD, FACP, Medical Director, Metabolic Nutrition and Weight Management, St. Joseph Mercy Oakland; Lifestyle Medicine Course Director, "Nutrition and The Metabolic Syndrome,", Harvard Medical...
